How to cite item

Reduction of driveline infections through doubled driveline tunneling of left ventricular assist devices—5-year follow-up

  
@article{JTD20711,
	author = {Leonhard Wert and Jasmin S. Hanke and Günes Dogan and Marcel Ricklefs and Felix Fleißner and Anamika Chatterjee and Christina Feldmann and Axel Haverich and Jan D. Schmitto},
	title = {Reduction of driveline infections through doubled driveline tunneling of left ventricular assist devices—5-year follow-up},
	journal = {Journal of Thoracic Disease},
	volume = {10},
	number = {Suppl 15},
	year = {2018},
	keywords = {},
	abstract = {Background: Driveline infection (DLI) is one of the leading causes for unplanned re-admissions of patients undergoing therapy with left ventricular assist devices (LVAD). In previous studies our group was able to show that a double tunneling implantation technique could significantly reduce infection rates  one year after implantation. We now report the results of the five-year-follow up of patients receiving the double tunneling technique.
Methods: We retrospectively analyzed patients receiving LVAD therapy with the HeartWare ventricular assist device (HVAD) (Medtronic, Minnesota, MN, USA) LVAD. For 36 patients (group 1) the driveline was tunneled via a conventional technique. In the remaining 33 patients (group 2) the drivelines were implanted by means of a double tunneling technique. The double tunnel driveline technique involved placement of the driveline in the sheath of the rectus muscle in the umbilical direction and then subcutaneously to the left (alternatively right) upper quadrant. We retrospectively compared both groups. Primary outcome parameters were infection rate and mortality.
Results: Five years after LVAD implantation the DLI rate of patients operated by a double tunneling technique was significantly lower than in the conventional technique group [61% (n=22) group 1 vs. 30% (n=10) group 2, P=0.004]. The 5-year mortality was lower in group 2 [42% (n=15) group 1 vs. 27% (n=9) group 2] but did not achieve statistical significance (P=0.10). The days of LVAD support between the two groups were comparable (1,275.56±885.89 group 1 vs. 1,321.94±711.37 group 2). The tunnel technique itself showed to be strongly associated with the occurrence of DLI. Other elevated variables are liver disease and dilated cardiomyopathy as primary disease.
Conclusions: Double tunneling technique for driveline implantation leads to significantly lowered infection rates after 5 years of LVAD therapy and it is associated with a lower mortality.},
	issn = {2077-6624},	url = {https://jtd.amegroups.org/article/view/20711}
}